REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/18/2025
Back to search
Official data from USPTO
AES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/19/2025
Trademark type
Combined
Nice classes
35, 42
Filing date
12/30/2019
Registration date
08/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/18/2020
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/01/2019
First use in commerce
05/01/2019
Drawing code
5
Owner type
03
Owner location
Doylestown, PA
Examiner
FREEMAN, BREANNA
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "AES" in a stylized font.
Holders and representatives
Holders
Synexus Clinical Research US, Inc.
Synexus Clinical Research US, Inc.
Representatives
Kenya L. Williams Thermo Fisher Scientific
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management of clinical trials for others; recruitment of clinical drug trial participantsposting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databasescollecting and compiling consumer preference information regarding health conditionsclinical trial participation interestclinical trial candidacy for business purposes; collection of market research informationcollecting and compiling clinical trial statistics and information for business purposes
Class 42
Clinical research and scientific analysis in the field of pharmaceutical drugsmedical devicesclinical trials
Publications
History of USPTO decisions and trademark events.
30 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/18/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/18/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/18/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/23/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/23/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/23/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/23/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/23/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/18/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/18/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/18/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/18/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2020
PUBO
PUBLISHED FOR OPPOSITION
06/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2020
ALIE
ASSIGNED TO LIE
04/27/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/31/2020
GNRT
NON-FINAL ACTION E-MAILED
03/31/2020
CNRT
NON-FINAL ACTION WRITTEN
03/31/2020
DOCK
ASSIGNED TO EXAMINER
03/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2020
NWAP
NEW APPLICATION ENTERED
01/02/2020
Continuous trademark protection
Get notified about every new filing that threatens AES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.